Xiao Zhang Huan Han Jiuzhou Zhao Xiao Liu Jianbo Zhang Rui Sun Shaomei Li Baoxing Liu Hui Zhu Shuyue Jiao Xiang Li Hong Tang
10.3389/fphar.2022.964606
Front Pharmacol
2022 Aug 17;13:964606.
egfr exon 20 insertion mutation n771_p772insh nsclc furmonertinib second-line
CC BY
https://pubmed.ncbi.nlm.nih.gov/36059942/
Case Reports
PMC9432720
36059942
Case Report: A good response to furmonertinib second-line treatment of an advanced lung adenocarcinoma patient with a rare EGFR exon 20 N771_P772insH mutation: A case report and literature review
2022